Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine

Australasian Journal of Dermatology

Volumn 39, Issue 1, 1998, Pages 29-30

  Watson, Alan B ^a,e   Marley, John E ^b   Ellis, David H ^c   Williams, Tony G ^d  

^a ROYAL NEWCASTLE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d NOVARTIS PHARMA AG   (Switzerland)

^e NONE   (Australia)

Author keywords

Fungal infection; Mycological culture treatment protocol

Indexed keywords

TERBINAFINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION CONTROL; LONG TERM CARE; MAJOR CLINICAL STUDY; NAIL DISEASE; ONYCHOMYCOSIS; TREATMENT OUTCOME;

EID: 0031977111     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.1998.tb01237.x     Document Type: Article

References (4)

1. Watson A, Marley J, Ellis D, Willams T. Terbinafine in onychomycosis of the toenail: A novel treatment protocol. J. Am. Acad. Dermatol. 1995; 33: 775-9.
2. Denning DW, Evans EGV, Kibbler CG et al. Fungal nail disease: A guide to good practice (report of a Working Group of the British Society for Medical Mycology). BMJ 1995; 311: 277-81.
3. Shear Nil, Gupta AK. Terbinafine for the treatment of pedal onychomycosis: A foot closer to the promised land of cured nails? Arch. Dermatol. 1995; 131: 937-42.
4. Finlay AY, Thomas R, Dykes PJ, Smith SG, Jones TC. Descriptive correlations between various doses of oral terbinafine and concentrations in the nail. J. Dermatol. Treat. 1994; 5: 193-7.